Breakthrough in mental health – world’s first clinical trials for take-home micro-dosing of LSD are underway.
Researchers have initiated the world’s first clinical trials involving the micro-dosing of a proprietary form of LSD as a potential at-home treatment for depression.
The study, spearheaded by leading mental health experts, aims to explore the therapeutic benefits of self-administered micro-doses in alleviating symptoms of depression.
This innovative approach, focused on personalised mental health care, marks a departure from traditional methodologies, signalling a potential revolution in how individuals manage their mental well-being.
Justin Hanka, Co-founder behind MindBio Therapeutics Corp, provides his first-hand insights on this mental health development.
#medical #mental health #lsd
